All companies
HBM Healthcare Investments logo

What smart money is saying about HBM Healthcare Investments

HBMN.SW

No fund has written a full thesis on HBM Healthcare Investments in our archive, but 1 fund letter reports a position in it — most recently Kavaljer Investmentbolagsfond in July 2026.

Get an email when a fund writes about it

Summarize with Warren AI
1
Reported positions
0
Bought
0
Sold
1
Letter

Position history

Every position in HBM Healthcare Investments on record in the archive was reported in Q3 2026, across 1 fund letter, with no move described.

Fund letters reporting a position in HBM Healthcare Investments, by quarter
QuarterLettersBoughtSoldTheses
Q3 20261000

Fund activity · 1 position

  • “BB Biotech & HBM Healthcare: Higher portfolio activity and clear market improvements In our monthly letter for December last year, we discussed a potential recovery in the healthcare sector. To our satisfaction, both BB Biotech and HBM Healthcare delivered reports that support the view that the recovery is now genuinely gathering pace. BB Biotech increased its net asset value by more than 17% during the second quarter, while HBM Healthcare rose 13%. High portfolio activity, clinical progress among the portfolio companies and elevated transaction activity in the sector lay behind the strong performance of both companies. Looking ahead, we see several interesting drivers in favour of the healthcare sector. Large pharmaceutical companies have more than USD 250 billion of revenue at risk of falling away by 2030 as patents on blockbuster drugs expire. One example is pharma giant Merck, which loses its core patent for the cancer drug Keytruda (with annual sales of around USD 25 billion) as early as 2028. The fastest way for the large caps to replace this revenue is to acquire already proven, differentiated innovation, which is pushing them out into the acquisition market. Here we see BB Biotech and HBM Healthcare as well positioned to benefit from this tailwind. BB Biotech and HBM Healthcare together account for 6.4% of Kavaljer Investmentbolagsfond”
    HBM Healthcare Investments

Read the letters behind these HBM Healthcare Investments positions

Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.

View plans→
Share this ledger